Fumihiko Hayakawa
Nagoya University(JP)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research
Most-Cited Works
- → Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines(2000)566 cited
- → Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases(2018)318 cited
- → Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults(2016)268 cited
- → A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations(2017)145 cited
- → Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells(2016)143 cited
- → Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis(2004)135 cited
- → c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300(2000)129 cited
- → Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment(2011)119 cited
- → Histone deacetylase 3 associates with and represses the transcription factor GATA-2(2001)111 cited
- → A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases(2013)108 cited